GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eternity Healthcare Inc (GREY:ETAH) » Definitions » ROE %

Eternity Healthcare (Eternity Healthcare) ROE % : 0.00% (As of Jul. 2018)


View and export this data going back to 2008. Start your Free Trial

What is Eternity Healthcare ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Eternity Healthcare's annualized net income for the quarter that ended in Jul. 2018 was $-0.72 Mil. Eternity Healthcare's average Total Stockholders Equity over the quarter that ended in Jul. 2018 was $-0.06 Mil. Therefore, Eternity Healthcare's annualized ROE % for the quarter that ended in Jul. 2018 was N/A%.

The historical rank and industry rank for Eternity Healthcare's ROE % or its related term are showing as below:

ETAH's ROE % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -0.54
* Ranked among companies with meaningful ROE % only.

Eternity Healthcare ROE % Historical Data

The historical data trend for Eternity Healthcare's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eternity Healthcare ROE % Chart

Eternity Healthcare Annual Data
Trend Apr09 Apr10 Apr11 Apr12 Apr13 Apr14 Apr15 Apr16 Apr17 Apr18
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -467.28 - - -

Eternity Healthcare Quarterly Data
Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - Negative Equity - -572.02 -

Competitive Comparison of Eternity Healthcare's ROE %

For the Medical Devices subindustry, Eternity Healthcare's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eternity Healthcare's ROE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eternity Healthcare's ROE % distribution charts can be found below:

* The bar in red indicates where Eternity Healthcare's ROE % falls into.



Eternity Healthcare ROE % Calculation

Eternity Healthcare's annualized ROE % for the fiscal year that ended in Apr. 2018 is calculated as

ROE %=Net Income (A: Apr. 2018 )/( (Total Stockholders Equity (A: Apr. 2017 )+Total Stockholders Equity (A: Apr. 2018 ))/ count )
=-0.315/( (-0.776+0.028)/ 2 )
=-0.315/-0.374
=N/A %

Eternity Healthcare's annualized ROE % for the quarter that ended in Jul. 2018 is calculated as

ROE %=Net Income (Q: Jul. 2018 )/( (Total Stockholders Equity (Q: Apr. 2018 )+Total Stockholders Equity (Q: Jul. 2018 ))/ count )
=-0.724/( (0.028+-0.145)/ 2 )
=-0.724/-0.0585
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jul. 2018) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.


Eternity Healthcare  (GREY:ETAH) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Jul. 2018 )
=Net Income/Total Stockholders Equity
=-0.724/-0.0585
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.724 / 0)*(0 / 2.3395)*(2.3395 / -0.0585)
=Net Margin %*Asset Turnover*Equity Multiplier
=N/A %*0*N/A
=ROA %*Equity Multiplier
=N/A %*N/A
=N/A %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Jul. 2018 )
=Net Income/Total Stockholders Equity
=-0.724/-0.0585
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-0.724 / -0.724) * (-0.724 / -0.732) * (-0.732 / 0) * (0 / 2.3395) * (2.3395 / -0.0585)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 0.9891 * N/A % * 0 * N/A
=N/A %

Note: The net income data used here is four times the quarterly (Jul. 2018) net income data. The Revenue data used here is four times the quarterly (Jul. 2018) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Eternity Healthcare ROE % Related Terms

Thank you for viewing the detailed overview of Eternity Healthcare's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Eternity Healthcare (Eternity Healthcare) Business Description

Traded in Other Exchanges
N/A
Address
18 Carnarvon Road, Flat/Room 1006 - 10th Floor, Hang Seng Tsim Sha Tsui Building, Tsim Sha TsuiI, Kowloon, Hong Kong, HKG
Eternity Healthcare Inc is a medical device company operating in the us. It focuses on manufacturing a needle-free injection system. The company emphasizes needle-free injection device technology for application in Diabetes, Pediatric Oncology, Multiple sclerosis, Multiple sclerosis, Anesthetics, Vaccine, Cardiovascular, and Migraine. The company adult stem cell storage is all located in North China, East China, and South China. The company targets market includes Guizhou, Yunan, Guangxi, Xinjiang, and Tibet.